tiprankstipranks
Advertisement
Advertisement

GMAB Stock Latest News

Genmab Ends Early GEN1047 Cancer Trial, Narrowing One Pipeline Bet
Company AnnouncementsGenmab Ends Early GEN1047 Cancer Trial, Narrowing One Pipeline Bet
1d ago
GMAB
Genmab, AbbVie provide clarification on Phase 3 EPCORE(R) DLBCL-1 trial
PremiumThe Fly
Genmab, AbbVie provide clarification on Phase 3 EPCORE(R) DLBCL-1 trial
2d ago
ABBV
GMAB
Genmab’s TIVDAK Cervical Cancer Trial Update: What a Termination Means for Investors
PremiumCompany Announcements
Genmab’s TIVDAK Cervical Cancer Trial Update: What a Termination Means for Investors
3d ago
GMAB
CoreWeave upgraded, IBM initiated: Wall Street’s top analyst calls
PremiumThe Fly
CoreWeave upgraded, IBM initiated: Wall Street’s top analyst calls
3d ago
PM
BKH
Genmab upgraded to Buy from Hold at TD Cowen
PremiumThe Fly
Genmab upgraded to Buy from Hold at TD Cowen
4d ago
GMAB
Genmab’s Petosemtamab Trial Takes Aim at a Key Colorectal Cancer Market
PremiumCompany AnnouncementsGenmab’s Petosemtamab Trial Takes Aim at a Key Colorectal Cancer Market
5d ago
GMAB
Genmab reports Q2 net sales of Darzalex $4.207B
Premium
The Fly
Genmab reports Q2 net sales of Darzalex $4.207B
11d ago
JNJ
GMAB
Buy Rating Reiterated on Genmab as DARZALEX Franchise Seen Defensible; $40 Price Target Maintained
Premium
Ratings
Buy Rating Reiterated on Genmab as DARZALEX Franchise Seen Defensible; $40 Price Target Maintained
13d ago
GMAB
Genmab says EC grants marketing authorization for Tepkinly combo
PremiumThe Fly
Genmab says EC grants marketing authorization for Tepkinly combo
19d ago
ABBV
GMAB
Genmab price target raised to $40 from $38 at H.C. Wainwright
PremiumThe Fly
Genmab price target raised to $40 from $38 at H.C. Wainwright
24d ago
GMAB
Blair adds American Express, Oracle to Conviction List in monthly update
PremiumThe Fly
Blair adds American Express, Oracle to Conviction List in monthly update
25d ago
P
CW
PremiumRatings
Genmab: Buy Rating Reiterated on Strong Epkinly Phase III Data and Late-Stage Pipeline; Price Target Unchanged at DKK 2,500
26d ago
GMAB
Genmab: Strong Phase III EPCORE DLBCL-4 Data and Major Label Expansion Opportunity Reinforce Buy Rating
PremiumRatingsGenmab: Strong Phase III EPCORE DLBCL-4 Data and Major Label Expansion Opportunity Reinforce Buy Rating
26d ago
GMAB
Genmab Reports Strong Phase 3 Data for Epcoritamab Combo in Relapsed/Refractory DLBCL
Premium
Company Announcements
Genmab Reports Strong Phase 3 Data for Epcoritamab Combo in Relapsed/Refractory DLBCL
26d ago
6K
GMAB
Genmab announces topline results from EPCORE DLBCL-4 trial
Premium
The Fly
Genmab announces topline results from EPCORE DLBCL-4 trial
26d ago
ABBV
GMAB
Genmab reports ‘positive’ Phase 3 results from EPCORE DLBCL-4 trial
PremiumThe Fly
Genmab reports ‘positive’ Phase 3 results from EPCORE DLBCL-4 trial
26d ago
GMAB
AbbVie reports ‘positive’ results from Phase 3 EPCORE DLBCL-4 trial
PremiumThe Fly
AbbVie reports ‘positive’ results from Phase 3 EPCORE DLBCL-4 trial
26d ago
ABBV
GMAB
Ram Selvaraju Reiterates Buy on Genmab, Keeps EPKINLY-Driven Outlook with Unchanged $38 Price Target
PremiumRatings
Ram Selvaraju Reiterates Buy on Genmab, Keeps EPKINLY-Driven Outlook with Unchanged $38 Price Target
1M ago
GMAB
Genmab Updates Articles of Association, Extends Capital-Raising Powers
PremiumCompany Announcements
Genmab Updates Articles of Association, Extends Capital-Raising Powers
1M ago
6K
GMAB
Genmab Announces Minor Capital Increase Following Employee Warrant Exercise
PremiumCompany AnnouncementsGenmab Announces Minor Capital Increase Following Employee Warrant Exercise
1M ago
6K
GMAB
Genmab Discloses Orbis as New 4.99% Major Shareholder
Premium
Company Announcements
Genmab Discloses Orbis as New 4.99% Major Shareholder
1M ago
6K
GMAB
Genmab Updates Articles of Association to Expand Capital-Raising Flexibility
Premium
Company Announcements
Genmab Updates Articles of Association to Expand Capital-Raising Flexibility
1M ago
6K
GMAB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >